Treglia, G.; Muoio, B.; Roustaei, H.; Kiamanesh, Z.; Aryana, K.; Sadeghi, R.
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review. Int. J. Mol. Sci. 2021, 22, 11192.
https://doi.org/10.3390/ijms222011192
AMA Style
Treglia G, Muoio B, Roustaei H, Kiamanesh Z, Aryana K, Sadeghi R.
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review. International Journal of Molecular Sciences. 2021; 22(20):11192.
https://doi.org/10.3390/ijms222011192
Chicago/Turabian Style
Treglia, Giorgio, Barbara Muoio, Hessamoddin Roustaei, Zahra Kiamanesh, Kamran Aryana, and Ramin Sadeghi.
2021. "Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review" International Journal of Molecular Sciences 22, no. 20: 11192.
https://doi.org/10.3390/ijms222011192
APA Style
Treglia, G., Muoio, B., Roustaei, H., Kiamanesh, Z., Aryana, K., & Sadeghi, R.
(2021). Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review. International Journal of Molecular Sciences, 22(20), 11192.
https://doi.org/10.3390/ijms222011192